Skip to main content
Top
Published in: Breast Cancer 2/2010

01-04-2010 | Case Report

Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q

Authors: Miwa Yoshida, Yukako Mouri, Sohei Yamamoto, Kyoko Yorozuya, Kimihito Fujii, Shogo Nakano, Takashi Fukutomi, Kazuo Hara, Hitoshi Tsuda

Published in: Breast Cancer | Issue 2/2010

Login to get access

Abstract

A 64-year-old man noticed a right subareolar mass in May 2005. On physical examination, an oval-shaped, well-circumscribedthe tumor (6.0 × 5.5 cm in size) was located just beneath the right nipple. The tumor was elastic, firm and freely movable. Neither axillary nor supraclavicular lymph nodes were palpable. Mammography demonstrated a 5 × 5-cm, relatively distinct and dense mass without microcalcifications or spiculations. There were no findings of concurrent gynecomastia. Ultrasonography revealed a large multilocular cyst with a mural hypoechoic protruding lesion exhibiting wide-based morphology with an irregular margin. On contrast-enhanced computed tomography, the inner lesion enhanced, but direct invasion of the tumor to the major pectoral muscle was not found. An intracystic papillary lesion, possibly papillary carcinoma, was suspected. In December 2007, wide excision of the tumor was performed. On histopathological examination, the tumor had a papillary pattern with a small cribriform component in the cystic wall with microinvasion of the stroma. Marginal status was negative. The final diagnosis of the disease was a microinvasive intracystic papillary carcinoma of low grade without axillary lymph node metastases. Immunohistochemically, estrogen receptor and progesterone receptor were both positive, but negative for HER-2 protein. No LOH on 16q could be detected. The prognosis of the disease was unclear; however, the malignant potential of this condition may be more clearly determined by studying the LOH on chromosome 16q.
Literature
1.
go back to reference Carter D. Intraductal papillary tumors of the breast: a study of 78 cases. Cancer. 1977;39:1689–92.CrossRefPubMed Carter D. Intraductal papillary tumors of the breast: a study of 78 cases. Cancer. 1977;39:1689–92.CrossRefPubMed
2.
go back to reference Tsuda H, Uei Y, Fukutomi T, Hirohashi S. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast. Jpn J Cancer Res. 1994;85:992–6.PubMed Tsuda H, Uei Y, Fukutomi T, Hirohashi S. Different incidence of loss of heterozygosity on chromosome 16q between intraductal papilloma and intracystic papillary carcinoma of the breast. Jpn J Cancer Res. 1994;85:992–6.PubMed
3.
go back to reference Kihara M, Mori N, Yamauchi A, Yokomise H. A case of intracystic papillary carcinoma with a multilocular cyst of the breast in male. Breast Cancer. 2004;11:409–12.CrossRefPubMed Kihara M, Mori N, Yamauchi A, Yokomise H. A case of intracystic papillary carcinoma with a multilocular cyst of the breast in male. Breast Cancer. 2004;11:409–12.CrossRefPubMed
4.
go back to reference Ikeda G, Suzaki M, Sakai H, Machishi H, Umeda K. A case of male intracystic carcinoma of the breast-review of the domestic cases of this disease. J Jpn Surg Assoc. 2006;67:2537–41. (in Japanese). Ikeda G, Suzaki M, Sakai H, Machishi H, Umeda K. A case of male intracystic carcinoma of the breast-review of the domestic cases of this disease. J Jpn Surg Assoc. 2006;67:2537–41. (in Japanese).
5.
go back to reference Kinoshita T, Fukutomi T, Iwamoto E, Takasugi M, Akashi-Tanaka S, Hasegawa T. Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast. 2005;14:322–4.CrossRefPubMed Kinoshita T, Fukutomi T, Iwamoto E, Takasugi M, Akashi-Tanaka S, Hasegawa T. Intracystic papillary carcinoma of the breast in a male patient diagnosed by core needle biopsy: a case report. Breast. 2005;14:322–4.CrossRefPubMed
6.
go back to reference Blaumeiser B, Tjalma WA, Verslegers I, Schepper AM, Buytaert P. Invasive papillary carcinoma of the male breast. Eur Radiol. 2002;12:2207–10.PubMed Blaumeiser B, Tjalma WA, Verslegers I, Schepper AM, Buytaert P. Invasive papillary carcinoma of the male breast. Eur Radiol. 2002;12:2207–10.PubMed
7.
go back to reference Nakahara S, Tsuji H, Tsukuda K, Ikeda E, Watanabe K, Kunitomo T. Dansei nouhou Nyuugann no 2 rei. Shujutsu. 2008;62:115–9. (in Japanese). Nakahara S, Tsuji H, Tsukuda K, Ikeda E, Watanabe K, Kunitomo T. Dansei nouhou Nyuugann no 2 rei. Shujutsu. 2008;62:115–9. (in Japanese).
8.
go back to reference Sinha S, Hughes RG, Ryley NG. Papillary carcinoma in a male breast cyst: a diagnostic challenge. Ann R Coll Surg Engl. 2006;88:1–3.CrossRef Sinha S, Hughes RG, Ryley NG. Papillary carcinoma in a male breast cyst: a diagnostic challenge. Ann R Coll Surg Engl. 2006;88:1–3.CrossRef
9.
go back to reference Hirotsu J, Koike K, Yokoyama G, Yanaga H, Hujii T, Shiromizu K. Dansei Nouhounai Nyuugan no 1 rei. Rinshou Kenkyuu. 2005;82:123–6. (in Japanese). Hirotsu J, Koike K, Yokoyama G, Yanaga H, Hujii T, Shiromizu K. Dansei Nouhounai Nyuugan no 1 rei. Rinshou Kenkyuu. 2005;82:123–6. (in Japanese).
10.
go back to reference Imoto S, Hasebe T. Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol. 1998;28:517–20.CrossRefPubMed Imoto S, Hasebe T. Intracystic papillary carcinoma of the breast in male: case report and review of the Japanese literature. Jpn J Clin Oncol. 1998;28:517–20.CrossRefPubMed
Metadata
Title
Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q
Authors
Miwa Yoshida
Yukako Mouri
Sohei Yamamoto
Kyoko Yorozuya
Kimihito Fujii
Shogo Nakano
Takashi Fukutomi
Kazuo Hara
Hitoshi Tsuda
Publication date
01-04-2010
Publisher
Springer Japan
Published in
Breast Cancer / Issue 2/2010
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-009-0101-4

Other articles of this Issue 2/2010

Breast Cancer 2/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine